D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LAZR
4001
DELISTED
Luminar Technologies
LAZR
| $110K | ﹤0.01% |
38,399
-481,841
| -93% | -$1.83M |
|
4002
Enovix
ENVX
$862M
| $109K | ﹤0.01% |
+12,010
| New | +$78.3K |
|
|
RDAGW
4003
Republic Digital Acquisition Co Warrants
RDAGW
| $108K | ﹤0.01% |
+150,000
| New | +$130K |
|
4004
Kodak
KODK
$806M
| $107K | ﹤0.01% |
19,026
+6,288
| +49% | +$37.8K |
|
4005
SES AI Corp Warrants
SES.WS
$4.82M
| $107K | ﹤0.01% |
988,099
| – | – |
|
4006
Capricor Therapeutics
CAPR
$1.14B
| $107K | ﹤0.01% |
+10,733
| New | +$113K |
|
|
BZUN
4007
Baozun
BZUN
$144M
| $105K | ﹤0.01% |
+41,943
| New | +$116K |
|
|
VTYX
4008
DELISTED
Ventyx Biosciences
VTYX
| $105K | ﹤0.01% |
48,932
-17,261
| -26% | -$27.9K |
|
4009
UNIFI
UFI
$117M
| $104K | ﹤0.01% |
19,980
-52,617
| -72% | -$259K |
|
4010
Arteris
AIP
$1.4B
| $104K | ﹤0.01% |
10,929
-13,768
| -56% | -$101K |
|
|
AVDL
4011
PUT
DELISTED
Avadel Pharmaceuticals
AVDL
| $103K | ﹤0.01% |
11,600
| – | – |
|
4012
PUT
Lucid Motors
LCID
$2.46B
| $102K | ﹤0.01% |
+4,820
| New | +$115K |
|
|
TACOW
4013
Berto Acquisition Corp Warrant
TACOW
$16.6M
| $99.4K | ﹤0.01% |
+125,000
| New | +$93.5K |
|
4014
Iovance Biotherapeutics
IOVA
$2.23B
| $95.4K | ﹤0.01% |
55,471
+16,195
| +41% | +$40.3K |
|
4015
CALL
New Fortress Energy
NFE
$101M
| $95.3K | ﹤0.01% |
28,700
+12,500
| +77% | +$54.3K |
|
|
RANGR
4016
Range Capital Acquisition Corp Rights
RANGR
| $93.8K | ﹤0.01% |
375,000
| – | – |
|
4017
Dave Inc Warrants
DAVEW
$34.3M
| $90.5K | ﹤0.01% |
49,200
| – | – |
|
4018
CALL
Sigma Lithium
SGML
$1.08B
| $87.8K | ﹤0.01% |
19,500
-70,600
| -78% | -$466K |
|
4019
eGain
EGAN
$176M
| $83.4K | ﹤0.01% |
13,350
-6,543
| -33% | -$35K |
|
|
RNWWW
4020
ReNew Energy Global PLC Warrant
RNWWW
$59.3K
| $78.8K | ﹤0.01% |
591,955
| – | – |
|
|
LAR
4021
Lithium Argentina AG
LAR
$958M
| $78.5K | ﹤0.01% |
+37,369
| New | +$74.4K |
|
4022
4D Molecular Therapeutics
FDMT
$526M
| $78.4K | ﹤0.01% |
21,135
-4,205
| -17% | -$14.8K |
|
|
ATYR
4023
aTyr Pharma
ATYR
$46.4M
| $77.5K | ﹤0.01% |
+15,286
| New | +$60.1K |
|
|
KIDZW
4024
KIDZ AI Inc Warrants
KIDZW
$233K
| $76.5K | ﹤0.01% |
+575,000
| New | +$88.9K |
|
|
DRDBW
4025
Roman DBDR Acquisition Corp II Warrants
DRDBW
| $75K | ﹤0.01% |
150,000
| – | – |
|
Similar funds
D.E. Shaw & Co's Q2 2025 Portfolio in Review
As of Q2 2025, D.E. Shaw & Co held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co deployed $7.51B of net new capital in Q2 2025, opening 647 new positions and adding to 1,556 existing holdings. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was GE Vernova, an estimated $768M trimmed.
- D.E. Shaw & Co's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- D.E. Shaw & Co added most to Apple in Q2 2025, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- D.E. Shaw & Co fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- D.E. Shaw & Co opened 647 new positions and closed 532 in Q2 2025.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.